Chief Executive Officer
Renaud became CEO in 2012, with a vision of increasing profitability and developing Curium into a global leader in nuclear medicine. He achieved this goal with great success, turning the organisation into a larger, more vertically-integrated institution with a global reach
Renaud is now leveraging Curium’s unique global infrastructure and proven industry experience to serve its nuclear medicine clients with an emphasis on compliance, service reliability, operational excellence and new product development.
One of Renaud’s main achievements has been to pull together the best team of more than 1700 members worldwide to take Curium through its vision and strategy.
Renaud has been part of Curium and its predecessors’ companies since 2009. Prior to his current role, he was Group COO and CEO Europe. Previously, he served in Arthur Andersen’s strategic consulting division, which he joined after graduating from the UK’s Warwick Business School.
Originally from Belgium, Renaud now lives in Washington DC with his wife and three children. In his spare time, he competes in triathlons and enjoys kite surfing.
Chief Executive Officer North America
Dan is Curium’s Chief Executive Officer, North America. He has executive responsibility for the organisation’s business in the region, across areas including Operations, Finance and Commercial, and is a member of Curium’s Executive Committee.
Dan has more than 18 years of experience within Curium’s Nuclear Medicine business and over 20 years’ experience in the healthcare industry.
Previously, Dan served as Vice President and General Manager of Global Nuclear Medicine for Mallinckrodt Pharmaceuticals, a multibillion-dollar specialty pharmaceutical company with U.S. headquarters in St Louis, Missouri. He also led their North American Imaging division as Vice President and General Manager.
Prior to joining Mallinckrodt in 1999, Dan worked at Stryker Corporation, a Fortune 500 medical technologies firm based in Kalamazoo, Michigan.
Dan holds a Bachelor’s degree in Education from the University of Wisconsin at La Crosse. Dan resides in St. Louis, Missouri with his wife and two children.
VP Global Branding
Sandy is Vice President Global Branding at Curium. She is responsible for establishing and driving a consistent global brand strategy internally and externally, to communicate Curium’s differentiated advantages, reinforce the brand’s leadership position in nuclear medicine, and build Curium’s reputation with its customers, distribution partners, industry associations, and the financial and healthcare community.
Internally, Sandy works collaboratively with cross-functional team members to establish brand champions and implement the regional brand strategy. Externally, she leads the development of Curium’s website, social media platform, press, publication, and other opportunities to deliver a consistent message and build awareness of Curium.
Sandy has 13 years of experience in Curium’s nuclear medicine business and 23 years in the healthcare industry. Previously, she served as Vice President Marketing North America, with responsibility for leading the development and execution of Curium’s strategic marketing plan and product strategy. She has extensive experience in marketing and communications across various industries.
Sandy holds a Bachelor’s degree in Marketing and an MBA from St. Louis University. She lives in St. Louis, Missouri, and is married with two children.
Group General Counsel
As Group General Counsel, Xavier leads Curium’s legal team.
In this role, he and his team support Curium’s operations in their day-to day-legal questions and challenges, ensure corporate housekeeping of all entities, act as Secretary to the Board and Committees of the parent entities, supervise compliance with Group policies, ensure proper insurance coverage of all activities and entities, and assist members of the Group Leadership Team in the Group’s M&A, CMO and in-licensing projects.
Xavier holds more than ten years’ experience working as Attorney at the Brussels Bar, followed by 15 years’ experience as Chief Legal Officer at Ion Beam Applications S.A., the Belgian listed company active in cyclotron manufacturing, proton-therapy and dosimetry, which owned IBA Molecular until 2012.
Xavier holds a Master-in-Law from the University of Louvain-la-Neuve, Belgium, and a Post Master in Economic Law from the University of Gent, Belgium. Married with three children, Xavier is a keen ultra-trail runner and mountain lover.
VP Group Business Development
As Global VP, Group Business Development, Ciril leads Curium’s strategy and corporate development.
In this role, he supports key growth initiatives at a group level, from ideation to scoping, business case modelling and implementation design – ensuring the Curium Group fulfils its mission, and is positioned on a sustainable, profitable growth track. This includes strategic planning, new product development, large-scale manufacturing and distribution partnerships, as well as supporting Curium’s inorganic initiatives.
Ciril has more than 15 years of experience in healthcare and strategy consulting, with a strong focus on growth strategy. Prior to his time at Curium, he served as Partner at one of the world’s leading management consultancies.
Cirl holds a Master’s degree from ESSEC Business School (Paris), and is married with four children. He is a keen marathon runner and acts as an active Board Member of ‘Petits Princes’, a wish-granting charity for critically-/chronically-ill children.
VP Northern Europe
Starting his career in the pharmaceutical industry as a sales rep, François moved into sales and marketing and, in 2000, joined the imaging market with a position at Amersham. Here he was responsible for sales and marketing for the France and Benelux regions.
In 2004, François joined Mallinckrodt as Sales and Marketing VP for Europe, where he was involved in the build-up of the European Covidien imaging business unit. Following this role, he joined IBA Molecular in 2009, where his position as Sales and Marketing VP for Europe saw him looking after the PET production centers.
Moving to the role of President, Europe with IBA Molecular, François’ scope of responsibility extended to include the Saclay production site. After leaving IBAM in 2014, he acted as consultant and transition manager for IRE Elit and Keosys, a French imaging software company.
In 2017, François was invited to join Curium, where his current responsibilities include P&L for Northern Europe, including the UK, Germany, the Nordics and all distributors for Europe except Portugal. He is focused on the development of Curium activities in these areas.
Chief Operating Officer
Régis is Chief Operating Officer, with executive responsibility over Curium’s European Operations and Global Purchasing, IT and R&D. He is a member of Curium’s Executive Committee.
Régis has over 28 years of experience with international companies such as Danone and Reckitt Benckiser, in the fast-moving consumer goods sector and the pharmaceutical industry.
He brings a wealth of experience in managing complex end-to-end manufacturing and supply chain organisations.
Régis has previously been engaged as COO and an Executive Member of the Board of a private equity owned confectionaries manufacturer. Prior to joining Curium in 2014, he was COO and Executive Member of the Board of a family-owned contract manufacturer in the pharmaceutical sector.
Head of Site, Prague Shared Service Center
Helle holds 20 years’ experience in customer service, with 15 years spent in a shared service environment within the IT and medical devices/pharmaceutical industries, in locations including the Netherlands, Belgium, Poland and the Czech Republic. She also combined and led two smaller SSCs from Italy and Belgium into a single, large SSC in Krakow, Poland.
In her current role as Head of Site, Prague Shared Service Center, for Curium, Helle is responsible for ensuring best-in-class service to all customers, both external and internal. She was previously engaged as Curium’s Director of Customer Care, EMEA.
A Six Sigma Greenbelt, Helle worked for PerkinElmer and Cisco Systems prior to joining Curium.
Originating from Denmark, she now lives in Prague with her husband and son.
Alejandro is VP International. He has responsibility over Curium’s businesses outside Europe and USA, leading the business over 53 countries including Curium’s Subsidiaries in Mexico, Brazil and Turkey.
Alejandro has more than four years of experience in Curium’s Nuclear Medicine businesses and in excess of 20 years in the healthcare industry, with a particular focus on the diagnostic imaging sector and nuclear medicine.
Previously, Alejandro served in different executive positions within GE Healthcare, including several overseas assignments in China and Brazil. He also led the nuclear medicine business in the EMEA region for three years, as well as spending five years as GM for Spain and Portugal.
Alejandro graduated in Molecular Biology at the University Autónoma of Madrid and obtained his PhD in Molecular Biology from the University of Santiago de Compostela. He also holds an MBA from Instituto de Empresa (IE) in Madrid.
Chief Financial Officer
As Curium’s Chief Financial Officer, Antoine has executive responsibility for the company’s finance worldwide, including group performance monitoring, planning, treasury and taxes. He is a member of Curium’s Executive Committee and has been on the main Board since October 2016.
Antoine holds more than 20 years’ experience in the pharmaceutical industry and is familiar with LBO environments. His previous roles include various senior financial management positions at Roussel-Uclaf (SANOFI) and AstraZeneca, working across Paris, New York and London.
Prior to joining Curium, Antoine was Group CFO for the private equity owned building materials group, Onduline.
Antoine graduated from the Institut d’Etudes Politiques (ScPoParis) and from the Harvard Business School (AMP). He holds a Master’s Degree in Economy from the University of Paris.
VP Group M&A and Integration
Chaitanya is a Vice President at Curium and leads the Group’s M&A and Integration efforts across the globe. In this role, he is responsible for defining and executing the Group’s strategy for inorganic growth, in close collaboration with the Group’s BD, Commercial and Operations teams. Chaitanya is a member of Curium’s Executive Committee.
Prior to joining Curium, Chaitanya had more than 11 years of professional experience in investment banking, and had executed more than 20 transactions for pharmaceuticals, diagnostics and healthcare services clients across the US, Europe and Asia. He has previously worked for the healthcare investment banking teams at Jefferies International, Bank of America Merrill Lynch and ABN AMRO banks in both London and Hong Kong.
Chaitanya holds an MBA from the Indian Institute of Management Ahmedabad and a Bachelor’s degree in Electronics and Communication Engineering from the Indian Institute of Technology, Kharagpur.
VP Southern Europe
Benoît is VP Southern Europe (France, Benelux, Italy and Spain ) and leads Curium’s operational activities across this region. In this role, he supports all commercial activities, as well as managing the European PET facility network of Curium.
His focus is to develop the PET business across the region and to maintain a high-level of service quality to Curium’s customers.
Benoît has more than 20 years of experience in the medical imaging field, in both radiology and nuclear medicine. Prior to joining IBA Molecular (now Curium), Benoît served as Contrast Media Business Unit Director for Covidien Germany.
Benoît holds a Master’s Degree in Biology from UPMC (Paris), and a Master’s degree in Health Law from Descartes University (Paris). He is married with two children.